Role of dopamine in malignant tumor growth
- PMID: 10963043
- DOI: 10.1385/ENDO:12:3:237
Role of dopamine in malignant tumor growth
Abstract
The regulatory role of dopamine, a monoamine neurotransmitter and/or a neurohormone in controlling the secretion of several anterior pituitary hormones, cardiovascular, and renal functions, has already been extensively used by clinicians for therapeutic purposes. In addition to these important functions of dopamine, some recent reports also indicate its novel role in regulating malignant cell proliferation and controlling immune functions in tumor-bearing animals. Therefore, in this article, we discuss all the relevant information correlating dopamine and malignant tumor growth in order to understand the host-tumor relationship at the level of a neurotransmitter and/or a neurohormone.
Similar articles
-
Failure of dopamine and bromocriptine to affect prolactin release and cell growth in the dopamine receptor-deficient 235-1 clone.Mol Cell Endocrinol. 1982 Oct;28(2):229-46. doi: 10.1016/0303-7207(82)90034-x. Mol Cell Endocrinol. 1982. PMID: 7128925
-
Differential actions of the dopamine agonist bromocriptine on growth of SMtTW tumors exhibiting a prolactin and/or a somatotroph cell phenotype: relation to dopamine D2 receptor expression.Endocrinology. 1999 Jan;140(1):13-21. doi: 10.1210/endo.140.1.6450. Endocrinology. 1999. PMID: 9886801
-
[The role of central catecholamines and dopaminergic receptors in the development of estrogen-induced adenohypophyseal hypertrophy].Cas Lek Cesk. 1995 May 17;134(10):296-301. Cas Lek Cesk. 1995. PMID: 7788647 Czech.
-
Neurotransmitter regulation of anterior pituitary hormones.Pharmacol Rev. 1985 Sep;37(3):249-332. Pharmacol Rev. 1985. PMID: 2869509 Review. No abstract available.
-
[Dopamine receptor subtypes].Med Pregl. 1996;49(7-8):281-5. Med Pregl. 1996. PMID: 8926944 Review. Croatian.
Cited by
-
Neurotransmitters as regulators of tumor angiogenesis and immunity: the role of catecholamines.J Neuroimmune Pharmacol. 2013 Mar;8(1):7-14. doi: 10.1007/s11481-012-9395-7. Epub 2012 Aug 11. J Neuroimmune Pharmacol. 2013. PMID: 22886869 Free PMC article. Review.
-
Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing.J Transl Med. 2019 Jun 4;17(1):189. doi: 10.1186/s12967-019-1941-0. J Transl Med. 2019. PMID: 31164161 Free PMC article.
-
Neurotransmitters: promising immune modulators in the tumor microenvironment.Front Immunol. 2023 May 5;14:1118637. doi: 10.3389/fimmu.2023.1118637. eCollection 2023. Front Immunol. 2023. PMID: 37215113 Free PMC article. Review.
-
Triggering Neurotransmitters Secretion from Single Cells by X-ray Nanobeam Irradiation.Nano Lett. 2020 May 13;20(5):3889-3894. doi: 10.1021/acs.nanolett.0c01046. Epub 2020 Apr 3. Nano Lett. 2020. PMID: 32227961 Free PMC article.
-
Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment.J Neuroimmune Pharmacol. 2015 Dec;10(4):610-9. doi: 10.1007/s11481-015-9626-9. Epub 2015 Jul 11. J Neuroimmune Pharmacol. 2015. PMID: 26162591 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources